Target intelligence / Profile preview

Cellular extracellular-matrix adhesion interface

Molecular classification
Protein complex, Structural assembly, Receptor family (Integrins), Intracellular signaling complex
01

Overview

Cellular extracellular-matrix (ECM) adhesion interfaces are specialized macromolecular assemblies that facilitate the physical and biochemical connection between a cell and its surrounding environment. These interfaces, primarily represented by focal adhesions and hemidesmosomes, consist of transmembrane receptors—most notably the integrin family—that link ECM components like collagen and fibronectin to the internal actin or intermediate filament cytoskeleton (Geiger et al., 2009). Beyond providing structural stability, these interfaces function as dynamic mechanosensors, converting mechanical forces into intracellular signals that govern essential processes such as proliferation, differentiation, and migration (Winograd-Katz et al., 2014). In pathological contexts, dysregulation of these adhesion sites is a driver of cancer metastasis, where tumor cells modulate adhesion to invade distant tissues, and in fibrotic diseases characterized by aberrant ECM remodeling (Hynes, 2002). While the interface itself is a complex structural entity rather than a single protein, its individual components, including various integrin heterodimers and associated signaling enzymes like Focal Adhesion Kinase (FAK), serve as high-value therapeutic targets in oncology, cardiology, and immunology (Humphries et al., 2019).

Other names
Focal adhesionCell-matrix junctionHemidesmosomeCell-ECM interfaceAdhesion complexIntegrin adhesome
02

Mechanism of action

Inhibition of transmembrane receptor (integrin) binding to extracellular matrix ligands or pharmacological inhibition of downstream intracellular signaling kinases such as Focal Adhesion Kinase (FAK) and Src.

03

Biological functions

Cell adhesionSignal transductionMechanotransductionCell migrationCell survivalCytoskeletal organization
04

Disease associations

CancerFibrosisCardiovascular diseaseInflammationMuscular dystrophyAutoimmune disease
05

Safety considerations

Increased bleeding riskImpaired wound healingRisk of progressive multifocal leukoencephalopathy (PML)ImmunosuppressionOff-target effects on tissue homeostasis
06

Interacting drugs

Abciximab

7 more in the full profile.

07

Biomarkers

Integrin alpha-v beta-3 expressionFocal adhesion kinase (FAK) phosphorylation statusPaxillin expression levelsIntegrin beta-1 activation state

Beyond the preview

Go deeper on Cellular extracellular-matrix adhesion interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cellular extracellular-matrix adhesion interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call